{"question_id": "blood-pressure-2025_sec-10-1_lookup_q01", "question": "What is recommended for adults with hypertension to minimize the risk of orthostatic hypotension?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-1"], "title_path": ["Complications of Management", "Management of OH"], "chapter_id": "sec-10", "subtopic_id": "sec-10-1", "char_count": 6160}}
{"question_id": "blood-pressure-2025_sec-10-1_scenario_q01", "question": "A 72-year-old man is on intensive blood pressure-lowering therapy but reports no symptoms of dizziness or fainting. What is the guideline's recommendation regarding his treatment goals for blood pressure?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-1"], "title_path": ["Complications of Management", "Management of OH"], "chapter_id": "sec-10", "subtopic_id": "sec-10-1", "char_count": 6160}}
{"question_id": "blood-pressure-2025_sec-10-1_sdm_q01", "question": "How can I effectively communicate to my patient the importance of monitoring for orthostatic hypotension when initiating or intensifying their antihypertensive treatment?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-1"], "title_path": ["Complications of Management", "Management of OH"], "chapter_id": "sec-10", "subtopic_id": "sec-10-1", "char_count": 6160}}
{"question_id": "blood-pressure-2025_sec-10-2_lookup_q01", "question": "What is the recommended management for adults experiencing a hypertensive emergency with evidence of acute target organ damage?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-2"], "title_path": ["Complications of Management", "Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"], "chapter_id": "sec-10", "subtopic_id": "sec-10-2", "char_count": 21288}}
{"question_id": "blood-pressure-2025_sec-10-2_scenario_q01", "question": "A 50-year-old female with a known history of aortic dissection comes to the hospital with a blood pressure of 210/140 mm Hg. How should her blood pressure be managed in the first hour of treatment?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-2"], "title_path": ["Complications of Management", "Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"], "chapter_id": "sec-10", "subtopic_id": "sec-10-2", "char_count": 21288}}
{"question_id": "blood-pressure-2025_sec-10-2_sdm_q01", "question": "In discussing treatment options for a patient presenting with a hypertensive emergency, how should I explain the importance of immediate blood pressure reduction and the potential risks of aggressive treatment?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-2"], "title_path": ["Complications of Management", "Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"], "chapter_id": "sec-10", "subtopic_id": "sec-10-2", "char_count": 21288}}
{"question_id": "blood-pressure-2025_sec-10-3_lookup_q01", "question": "What are the common antihypertensive medications associated with erectile dysfunction in men, and which medication is noted for having the most favorable profile?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-3"], "title_path": ["Complications of Management", "Sexual Dysfunction"], "chapter_id": "sec-10", "subtopic_id": "sec-10-3", "char_count": 1881}}
{"question_id": "blood-pressure-2025_sec-10-3_scenario_q01", "question": "A 55-year-old man who has been on an ACE inhibitor for hypertension presents with erectile dysfunction. Considering the medication's profile, what are the next steps in managing his sexual health?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-3"], "title_path": ["Complications of Management", "Sexual Dysfunction"], "chapter_id": "sec-10", "subtopic_id": "sec-10-3", "char_count": 1881}}
{"question_id": "blood-pressure-2025_sec-10-3_sdm_q01", "question": "How can I effectively discuss the potential impacts of antihypertensive medications on my patient's sexual function to ensure they feel comfortable addressing any concerns?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-3"], "title_path": ["Complications of Management", "Sexual Dysfunction"], "chapter_id": "sec-10", "subtopic_id": "sec-10-3", "char_count": 1881}}
{"question_id": "blood-pressure-2025_sec-10-4_lookup_q01", "question": "What should be done regarding beta-blockers in patients with hypertension who are scheduled for major surgery and have been taking them chronically?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-4"], "title_path": ["Complications of Management", "Patients Scheduled for Surgical Procedures"], "chapter_id": "sec-10", "subtopic_id": "sec-10-4", "char_count": 10094}}
{"question_id": "blood-pressure-2025_sec-10-4_scenario_q01", "question": "A 65-year-old woman with a history of hypertension is scheduled for elective hip replacement surgery. She has been stable on her current antihypertensive regimen. Should her medications be continued throughout the perioperative period?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-4"], "title_path": ["Complications of Management", "Patients Scheduled for Surgical Procedures"], "chapter_id": "sec-10", "subtopic_id": "sec-10-4", "char_count": 10094}}
{"question_id": "blood-pressure-2025_sec-10-4_sdm_q01", "question": "How can I effectively communicate to a patient scheduled for major surgery the importance of continuing their beta-blocker therapy during the perioperative period for better blood pressure control?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-10-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-10", "sec-10-4"], "title_path": ["Complications of Management", "Patients Scheduled for Surgical Procedures"], "chapter_id": "sec-10", "subtopic_id": "sec-10-4", "char_count": 10094}}
{"question_id": "blood-pressure-2025_sec-6-1_lookup_q01", "question": "How should blood pressure be categorized for adults to effectively prevent and treat high blood pressure according to the 2025 AHA guidelines?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classification of BP", "Definition of High BP"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 5610}}
{"question_id": "blood-pressure-2025_sec-6-1_scenario_q01", "question": "A 62-year-old man with a history of obesity and diabetes presents with a blood pressure of 145/90 mmHg. What classification should be applied to his blood pressure based on the current recommendations?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classification of BP", "Definition of High BP"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 5610}}
{"question_id": "blood-pressure-2025_sec-6-1_sdm_q01", "question": "How can I explain to my patient the importance of categorizing their blood pressure as normal, elevated, or hypertensive, and how this classification affects their treatment options?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classification of BP", "Definition of High BP"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 5610}}
{"question_id": "blood-pressure-2025_sec-7-1_lookup_q01", "question": "What standardized methods are recommended for the accurate measurement and documentation of in-office blood pressure when diagnosing and managing high blood pressure in adults?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Patient Evaluation"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 30417}}
{"question_id": "blood-pressure-2025_sec-7-1_scenario_q01", "question": "A 47-year-old female patient with newly diagnosed hypertension reports feeling anxious during her office visits, leading to elevated blood pressure readings. What out-of-office blood pressure monitoring method is recommended to confirm her diagnosis?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Patient Evaluation"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 30417}}
{"question_id": "blood-pressure-2025_sec-7-1_sdm_q01", "question": "When discussing the importance of accurate blood pressure measurement with a patient who has recently been diagnosed with hypertension, how can I effectively explain the benefits of using standardized methods and the implications of inaccurate readings on their treatment plan?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Patient Evaluation"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 30417}}
{"question_id": "blood-pressure-2025_sec-7-2_lookup_q01", "question": "What is the recommended approach for adults with untreated office systolic blood pressure of 130 mm Hg or higher to exclude white-coat hypertension before making a diagnosis?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Patient Diagnosis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 60690}}
{"question_id": "blood-pressure-2025_sec-7-2_scenario_q01", "question": "A 62-year-old man with a history of resistant hypertension is currently on multiple antihypertensive medications. His office blood pressure is recorded at 150/95 mm Hg today. What does the guideline recommend regarding out-of-office blood pressure monitoring to exclude a white-coat effect?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Patient Diagnosis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 60690}}
{"question_id": "blood-pressure-2025_sec-7-2_sdm_q01", "question": "How can I effectively communicate the need for out-of-office blood pressure monitoring to a patient with suspected white-coat hypertension to help them understand its importance in confirming their diagnosis?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Patient Diagnosis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 60690}}
{"question_id": "blood-pressure-2025_sec-8_lookup_q01", "question": "What healthy lifestyle behaviors are recommended to prevent hypertension, particularly for those who may have a genetic predisposition?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Prevention Strategies"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 1096}}
{"question_id": "blood-pressure-2025_sec-8_scenario_q01", "question": "What lifestyle changes should I recommend to a 45-year-old woman with a BMI of 29 who is concerned about developing high blood pressure?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Prevention Strategies"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 1096}}
{"question_id": "blood-pressure-2025_sec-8_sdm_q01", "question": "How can I effectively discuss the importance of a heart-healthy diet and sodium intake with my patient who is concerned about making drastic dietary changes?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Prevention Strategies"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 1096}}
{"question_id": "blood-pressure-2025_sec-9-1_lookup_q01", "question": "What weight loss goal is recommended for adults with overweight or obesity to prevent or treat elevated blood pressure and hypertension?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["BP Management", "Lifestyle and Psychosocial Approaches"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 24210}}
{"question_id": "blood-pressure-2025_sec-9-1_scenario_q01", "question": "A 38-year-old man with elevated blood pressure reports consuming two alcoholic drinks daily. What guidance does the guideline provide regarding alcohol consumption for someone in his situation?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["BP Management", "Lifestyle and Psychosocial Approaches"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 24210}}
{"question_id": "blood-pressure-2025_sec-9-1_sdm_q01", "question": "How can I effectively communicate the importance of weight loss to a 55-year-old male patient who is struggling with obesity and has elevated blood pressure, emphasizing the goal of at least 5% body weight reduction?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["BP Management", "Lifestyle and Psychosocial Approaches"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 24210}}
{"question_id": "blood-pressure-2025_sec-9-2_lookup_q01", "question": "What is the recommended threshold for initiating antihypertensive medication in adults with hypertension when their average systolic blood pressure is 140 mm Hg or greater?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["BP Management", "Medical Management"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 100163}}
{"question_id": "blood-pressure-2025_sec-9-2_scenario_q01", "question": "A 62-year-old woman with a history of diabetes presents with a blood pressure reading of 135/85 mm Hg. Given her risk factors, should we initiate antihypertensive medications for her?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["BP Management", "Medical Management"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 100163}}
{"question_id": "blood-pressure-2025_sec-9-2_sdm_q01", "question": "How can I explain to a patient with stage 1 hypertension and diabetes the importance of starting antihypertensive medication when their blood pressure is only slightly elevated?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["BP Management", "Medical Management"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 100163}}
{"question_id": "blood-pressure-2025_sec-9-3_lookup_q01", "question": "What is the recommended blood pressure treatment goal for adults with type 2 diabetes and hypertension, and at what systolic blood pressure should antihypertensive treatment be initiated?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-3"], "title_path": ["BP Management", "Comorbidities"], "chapter_id": "sec-9", "subtopic_id": "sec-9-3", "char_count": 67891}}
{"question_id": "blood-pressure-2025_sec-9-3_scenario_q01", "question": "A 72-year-old man with a history of hypertension and chronic kidney disease presents with an eGFR of 50 mL/min/1.73 m². What should be the target SBP for his hypertension management?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-3"], "title_path": ["BP Management", "Comorbidities"], "chapter_id": "sec-9", "subtopic_id": "sec-9-3", "char_count": 67891}}
{"question_id": "blood-pressure-2025_sec-9-3_sdm_q01", "question": "In managing a 65-year-old male patient with hypertension and chronic kidney disease, how should I explain the importance of controlling his blood pressure to prevent further kidney damage, and what specific treatment options can I discuss with him?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-3"], "title_path": ["BP Management", "Comorbidities"], "chapter_id": "sec-9", "subtopic_id": "sec-9-3", "char_count": 67891}}
{"question_id": "blood-pressure-2025_sec-9-4_lookup_q01", "question": "What is the recommended approach for managing adults with uncontrolled hypertension to achieve and maintain blood pressure control?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-4"], "title_path": ["BP Management", "Plan of Care for Hypertension"], "chapter_id": "sec-9", "subtopic_id": "sec-9-4", "char_count": 23726}}
{"question_id": "blood-pressure-2025_sec-9-4_scenario_q01", "question": "A 48-year-old woman with uncontrolled hypertension is currently on two antihypertensive medications but still has a blood pressure of 150/95 mm Hg. What steps should we take to assess her medication adherence and treatment response?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-4"], "title_path": ["BP Management", "Plan of Care for Hypertension"], "chapter_id": "sec-9", "subtopic_id": "sec-9-4", "char_count": 23726}}
{"question_id": "blood-pressure-2025_sec-9-4_sdm_q01", "question": "How can I effectively communicate the importance of a team-based care approach to my patient with uncontrolled hypertension, and what should I emphasize about the roles of different team members in their management?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-4"], "title_path": ["BP Management", "Plan of Care for Hypertension"], "chapter_id": "sec-9", "subtopic_id": "sec-9-4", "char_count": 23726}}
{"question_id": "blood-pressure-2025_sec-9-5_lookup_q01", "question": "What antihypertensive medications are preferred for individuals with hypertension who are planning a pregnancy or who become pregnant?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-5"], "title_path": ["BP Management", "Hypertension and Pregnancy"], "chapter_id": "sec-9", "subtopic_id": "sec-9-5", "char_count": 23860}}
{"question_id": "blood-pressure-2025_sec-9-5_scenario_q01", "question": "A 28-year-old female patient with chronic hypertension diagnosed before pregnancy is currently 18 weeks along. What blood pressure target should she aim for to prevent complications?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-5"], "title_path": ["BP Management", "Hypertension and Pregnancy"], "chapter_id": "sec-9", "subtopic_id": "sec-9-5", "char_count": 23860}}
{"question_id": "blood-pressure-2025_sec-9-5_sdm_q01", "question": "How can I effectively communicate the importance of using labetalol or extended-release nifedipine to a pregnant patient with hypertension, ensuring she understands the benefits to both her and her baby?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-5"], "title_path": ["BP Management", "Hypertension and Pregnancy"], "chapter_id": "sec-9", "subtopic_id": "sec-9-5", "char_count": 23860}}
{"question_id": "blood-pressure-2025_sec-9-6_lookup_q01", "question": "What evaluation is recommended for adults with resistant hypertension to identify secondary causes and simplify treatment?", "question_style": "lookup", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-6"], "title_path": ["BP Management", "Resistant Hypertension and Renal Denervation"], "chapter_id": "sec-9", "subtopic_id": "sec-9-6", "char_count": 33941}}
{"question_id": "blood-pressure-2025_sec-9-6_scenario_q01", "question": "A 55-year-old man presents with resistant hypertension, currently on three medications: an ARB, a CCB, and a thiazide-like diuretic. His eGFR is 50 mL/min. He has been adherent to his medications but continues to have an office BP of 150/95 mm Hg. What does the guideline suggest for managing his blood pressure?", "question_style": "scenario", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-6"], "title_path": ["BP Management", "Resistant Hypertension and Renal Denervation"], "chapter_id": "sec-9", "subtopic_id": "sec-9-6", "char_count": 33941}}
{"question_id": "blood-pressure-2025_sec-9-6_sdm_q01", "question": "How can I effectively communicate the need for a detailed evaluation of secondary causes in a patient with resistant hypertension who is hesitant about undergoing additional tests?", "question_style": "sdm", "guideline_id": "blood-pressure-2025", "guideline_name": "2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults", "source": {"node_id": "sec-9-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-6"], "title_path": ["BP Management", "Resistant Hypertension and Renal Denervation"], "chapter_id": "sec-9", "subtopic_id": "sec-9-6", "char_count": 33941}}
{"question_id": "cvd-prevention-2019_sec-5-1_lookup_q01", "question": "What approach is recommended for managing risk factors associated with ASCVD in a team-based care setting?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-1"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Patient-Centered Approaches to Comprehensive ASCVD Prevention"], "chapter_id": "sec-5", "subtopic_id": "sec-5-1", "char_count": 2019}}
{"question_id": "cvd-prevention-2019_sec-5-1_scenario_q01", "question": "A 50-year-old man presents with a family history of cardiovascular disease and is looking for ways to lower his risk. According to the guidelines, how should shared decision-making be utilized in his care plan?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-1"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Patient-Centered Approaches to Comprehensive ASCVD Prevention"], "chapter_id": "sec-5", "subtopic_id": "sec-5-1", "char_count": 2019}}
{"question_id": "cvd-prevention-2019_sec-5-1_sdm_q01", "question": "How can I effectively communicate the importance of a team-based care approach to a patient who is hesitant about involving multiple healthcare providers in their ASCVD risk management?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-1"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Patient-Centered Approaches to Comprehensive ASCVD Prevention"], "chapter_id": "sec-5", "subtopic_id": "sec-5-1", "char_count": 2019}}
{"question_id": "cvd-prevention-2019_sec-5-2_lookup_q01", "question": "What key elements do the 2019 ACC/AHA guidelines emphasize for effective ASCVD prevention efforts in clinical practice?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-2"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-2", "char_count": 515}}
{"question_id": "cvd-prevention-2019_sec-5-2_scenario_q01", "question": "A 62-year-old woman with a history of hypertension and hyperlipidemia comes to the clinic for a routine check-up. She is currently taking lisinopril and atorvastatin. What recommendations should we consider for her regarding the prevention of cardiovascular disease?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-2"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-2", "char_count": 515}}
{"question_id": "cvd-prevention-2019_sec-5-2_sdm_q01", "question": "How can I effectively communicate the importance of team-based care and shared decision-making in preventing atherosclerotic cardiovascular disease (ASCVD) to my patient?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-2"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-2", "char_count": 515}}
{"question_id": "cvd-prevention-2019_sec-5-3_lookup_q01", "question": "What types of approaches have demonstrated greater reductions in ASCVD risk compared to usual care in patients with hypertension, diabetes, and hyperlipidemia?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-3"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-3", "char_count": 6325}}
{"question_id": "cvd-prevention-2019_sec-5-3_scenario_q01", "question": "A 45-year-old man recently diagnosed with type 2 diabetes is anxious about managing his cardiovascular risk. How can we involve him in shared decision-making regarding lifestyle changes and potential medical therapies for ASCVD prevention?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-3"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-3", "char_count": 6325}}
{"question_id": "cvd-prevention-2019_sec-5-3_sdm_q01", "question": "How can I effectively communicate the importance of team-based care in managing my patient's ASCVD risk, particularly for those with diabetes and hypertension?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-3"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-3", "char_count": 6325}}
{"question_id": "cvd-prevention-2019_sec-5-5_lookup_q01", "question": "What should be considered when estimating the 10-year ASCVD risk for individual patients to guide preventive interventions?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-5"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-5", "char_count": 2009}}
{"question_id": "cvd-prevention-2019_sec-5-5_scenario_q01", "question": "A 39-year-old woman with a family history of premature coronary artery disease and high cholesterol levels is seeking advice on lifestyle changes. What should we do to assess her ASCVD risk and discuss both lifestyle and potential pharmacotherapy?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-5"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-5", "char_count": 2009}}
{"question_id": "cvd-prevention-2019_sec-5-5_sdm_q01", "question": "How can I effectively communicate the importance of a 10-year ASCVD risk assessment to my patient before discussing preventive treatment options?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-5"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Synopsis"], "chapter_id": "sec-5", "subtopic_id": "sec-5-5", "char_count": 2009}}
{"question_id": "cvd-prevention-2019_sec-5-6_lookup_q01", "question": "What screening method is recommended to estimate 10-year ASCVD risk for asymptomatic adults aged 40 to 75?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-6"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-6", "char_count": 13436}}
{"question_id": "cvd-prevention-2019_sec-5-6_scenario_q01", "question": "A 39-year-old white female with a history of gestational diabetes has a blood pressure of 138/88 mm Hg. Her 10-year ASCVD risk is estimated at 9%. What lifestyle interventions should be recommended?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-6"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-6", "char_count": 13436}}
{"question_id": "cvd-prevention-2019_sec-5-6_sdm_q01", "question": "How can I effectively communicate the importance of evaluating a patient's 10-year ASCVD risk when discussing lifestyle changes and potential medication for someone with stage 1 hypertension?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-5-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-5", "sec-5-6"], "title_path": ["Overarching Recommendations for ASCVD Prevention Efforts", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-5", "subtopic_id": "sec-5-6", "char_count": 13436}}
{"question_id": "cvd-prevention-2019_sec-6-1_lookup_q01", "question": "What dietary changes are recommended to lower the risk factors associated with atherosclerotic cardiovascular disease?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Nutrition and Diet"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2619}}
{"question_id": "cvd-prevention-2019_sec-6-1_scenario_q01", "question": "A 67-year-old man who has been advised to improve his heart health is interested in what processed foods he should limit in his diet. What recommendations should he follow to minimize his cardiovascular risk?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Nutrition and Diet"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2619}}
{"question_id": "cvd-prevention-2019_sec-6-1_sdm_q01", "question": "How can I effectively discuss the importance of a diet rich in vegetables, fruits, and whole grains with a patient who is hesitant to change their eating habits?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Nutrition and Diet"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2619}}
{"question_id": "cvd-prevention-2019_sec-6-3_lookup_q01", "question": "What dietary patterns are associated with lower all-cause mortality according to the 2019 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-3"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-3", "char_count": 6737}}
{"question_id": "cvd-prevention-2019_sec-6-3_scenario_q01", "question": "A 65-year-old woman with hypertension and a BMI of 30 is looking to improve her diet to reduce her cardiovascular risk. What dietary changes should she consider to align with the recommended guidelines?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-3"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-3", "char_count": 6737}}
{"question_id": "cvd-prevention-2019_sec-6-3_sdm_q01", "question": "How can I effectively communicate the benefits of a Mediterranean diet to a 55-year-old male patient with high blood pressure who is skeptical about changing his eating habits?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-3"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-3", "char_count": 6737}}
{"question_id": "cvd-prevention-2019_sec-6-4_lookup_q01", "question": "What is the recommended amount of aerobic physical activity for adults to reduce their risk of atherosclerotic cardiovascular disease?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-4"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Exercise and Physical Activity"], "chapter_id": "sec-6", "subtopic_id": "sec-6-4", "char_count": 2466}}
{"question_id": "cvd-prevention-2019_sec-6-4_scenario_q01", "question": "For a 45-year-old man who currently exercises only 30 minutes a week, what is the guideline recommendation for the amount of aerobic physical activity he should aim for to lower his ASCVD risk?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-4"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Exercise and Physical Activity"], "chapter_id": "sec-6", "subtopic_id": "sec-6-4", "char_count": 2466}}
{"question_id": "cvd-prevention-2019_sec-6-4_sdm_q01", "question": "How can I effectively counsel a 65-year-old patient who is hesitant to increase their physical activity levels due to concerns about injury, while emphasizing the importance of at least 150 minutes of moderate-intensity exercise per week?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-4"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Exercise and Physical Activity"], "chapter_id": "sec-6", "subtopic_id": "sec-6-4", "char_count": 2466}}
{"question_id": "cvd-prevention-2019_sec-6-5_lookup_q01", "question": "What are the recommended strategies to increase physical activity among adults who do not meet the minimum recommendations for cardiovascular health?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-5"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-6", "subtopic_id": "sec-6-5", "char_count": 1708}}
{"question_id": "cvd-prevention-2019_sec-6-5_scenario_q01", "question": "What exercise recommendations should I provide to a 65-year-old woman who has been sedentary but wants to improve her cardiovascular health?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-5"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-6", "subtopic_id": "sec-6-5", "char_count": 1708}}
{"question_id": "cvd-prevention-2019_sec-6-5_sdm_q01", "question": "How can I encourage a sedentary patient to start an exercise program while addressing their concerns about safety and intensity?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-5"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-6", "subtopic_id": "sec-6-5", "char_count": 1708}}
{"question_id": "cvd-prevention-2019_sec-6-6_lookup_q01", "question": "What is the minimum recommended amount of moderate-intensity aerobic physical activity for all adults to lower the risk of atherosclerotic cardiovascular disease (ASCVD) according to the 2019 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-6"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-6", "char_count": 6966}}
{"question_id": "cvd-prevention-2019_sec-6-6_scenario_q01", "question": "A 45-year-old man is currently active for about 60 minutes a week, mostly walking slowly and doing light housework. He wants to improve his cardiovascular health. What amount and type of physical activity should I encourage him to achieve?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-6"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-6", "char_count": 6966}}
{"question_id": "cvd-prevention-2019_sec-6-6_sdm_q01", "question": "How can I effectively counsel a patient who is currently sedentary and resistant to increasing their physical activity levels, especially regarding the benefits of even small amounts of moderate-to-vigorous exercise?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-6-6", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-6"], "title_path": ["Lifestyle Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-6", "subtopic_id": "sec-6-6", "char_count": 6966}}
{"question_id": "cvd-prevention-2019_sec-7-10_lookup_q01", "question": "What nonpharmacological interventions are recommended for adults with elevated blood pressure or hypertension to help reduce their blood pressure?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-10", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-10"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Pressure or Hypertension"], "chapter_id": "sec-7", "subtopic_id": "sec-7-10", "char_count": 5009}}
{"question_id": "cvd-prevention-2019_sec-7-10_scenario_q01", "question": "For a 50-year-old man with confirmed hypertension and a history of chronic kidney disease, what should be the target blood pressure according to the guidelines?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-10", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-10"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Pressure or Hypertension"], "chapter_id": "sec-7", "subtopic_id": "sec-7-10", "char_count": 5009}}
{"question_id": "cvd-prevention-2019_sec-7-10_sdm_q01", "question": "How can I effectively discuss nonpharmacological interventions for managing hypertension with a patient who is hesitant to change their lifestyle?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-10", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-10"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Pressure or Hypertension"], "chapter_id": "sec-7", "subtopic_id": "sec-7-10", "char_count": 5009}}
{"question_id": "cvd-prevention-2019_sec-7-11_lookup_q01", "question": "What are the recommended actions for individuals with elevated blood pressure defined as 120–129/<80 mm Hg according to the 2019 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-11", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-11"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-11", "char_count": 4369}}
{"question_id": "cvd-prevention-2019_sec-7-11_scenario_q01", "question": "A 66-year-old woman presents with a blood pressure of 130/85 mm Hg and no significant history of cardiovascular disease. What should be the management strategy according to current recommendations?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-11", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-11"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-11", "char_count": 4369}}
{"question_id": "cvd-prevention-2019_sec-7-11_sdm_q01", "question": "How can I effectively communicate the importance of managing elevated blood pressure to a 55-year-old male patient who has been noncompliant with lifestyle changes and is hesitant about starting medication?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-11", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-11"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-11", "char_count": 4369}}
{"question_id": "cvd-prevention-2019_sec-7-13_lookup_q01", "question": "What should be assessed at every healthcare visit for all adults regarding tobacco use?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-13", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-13"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Treatment of Tobacco Use"], "chapter_id": "sec-7", "subtopic_id": "sec-7-13", "char_count": 2521}}
{"question_id": "cvd-prevention-2019_sec-7-13_scenario_q01", "question": "A 38-year-old man is a heavy smoker and has recently been diagnosed with hypertension. What is the recommended approach for managing his tobacco use in relation to his cardiovascular risk?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-13", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-13"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Treatment of Tobacco Use"], "chapter_id": "sec-7", "subtopic_id": "sec-7-13", "char_count": 2521}}
{"question_id": "cvd-prevention-2019_sec-7-13_sdm_q01", "question": "How can I effectively communicate the importance of assessing tobacco use during every healthcare visit to a patient who may not see it as a priority?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-13", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-13"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Treatment of Tobacco Use"], "chapter_id": "sec-7", "subtopic_id": "sec-7-13", "char_count": 2521}}
{"question_id": "cvd-prevention-2019_sec-7-14_lookup_q01", "question": "What does the 2019 ACC/AHA guideline recommend regarding tobacco cessation treatment in clinical settings for all tobacco users?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-14", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-14"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-14", "char_count": 1215}}
{"question_id": "cvd-prevention-2019_sec-7-14_scenario_q01", "question": "A 38-year-old woman who has never smoked but is frequently exposed to secondhand smoke at home is concerned about her risk for cardiovascular disease. What does the guideline recommend regarding her exposure and its implications for her health?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-14", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-14"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-14", "char_count": 1215}}
{"question_id": "cvd-prevention-2019_sec-7-14_sdm_q01", "question": "How can I effectively communicate to my patient the risks associated with smoking and the benefits of cessation, especially if they express doubt about the severity of their tobacco use?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-14", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-14"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-14", "char_count": 1215}}
{"question_id": "cvd-prevention-2019_sec-7-15_lookup_q01", "question": "What are the recommended screening questions for assessing tobacco use status in adults during healthcare visits?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-15", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-15"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-15", "char_count": 6971}}
{"question_id": "cvd-prevention-2019_sec-7-15_scenario_q01", "question": "For a 60-year-old man who has recently been diagnosed with hypertension and is a former smoker, how should we approach his tobacco use history during his follow-up visit?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-15", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-15"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-15", "char_count": 6971}}
{"question_id": "cvd-prevention-2019_sec-7-15_sdm_q01", "question": "How can I effectively communicate the importance of discussing tobacco use with my patients, especially those who may not initially disclose their smoking status?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-15", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-15"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-15", "char_count": 6971}}
{"question_id": "cvd-prevention-2019_sec-7-17_lookup_q01", "question": "What are the considerations regarding aspirin use for primary prevention of ASCVD in patients without prior history of the disease?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-17", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-17"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-17", "char_count": 1382}}
{"question_id": "cvd-prevention-2019_sec-7-17_scenario_q01", "question": "A 62-year-old woman with hypertension and hyperlipidemia has no prior history of cardiovascular disease. Should she be started on aspirin for primary prevention?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-17", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-17"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-17", "char_count": 1382}}
{"question_id": "cvd-prevention-2019_sec-7-17_sdm_q01", "question": "How can I effectively communicate the risks and benefits of aspirin for primary prevention of cardiovascular disease to my patient who has no prior history of ASCVD?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-17", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-17"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-17", "char_count": 1382}}
{"question_id": "cvd-prevention-2019_sec-7-18_lookup_q01", "question": "What is the recommended approach to prophylactic aspirin use for adults aged 40 to 70 years regarding their ASCVD risk and bleeding risk factors?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-18", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-18"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-18", "char_count": 5914}}
{"question_id": "cvd-prevention-2019_sec-7-18_scenario_q01", "question": "A 58-year-old man with type 2 diabetes and an estimated 12% 10-year ASCVD risk is asking about starting low-dose aspirin for primary prevention. Given his risk factors, what should be considered according to the guideline?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-18", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-18"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-18", "char_count": 5914}}
{"question_id": "cvd-prevention-2019_sec-7-18_sdm_q01", "question": "How can I effectively communicate the potential benefits and risks of starting low-dose aspirin for primary prevention to a 65-year-old male patient with a family history of premature heart disease?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-18", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-18"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-18", "char_count": 5914}}
{"question_id": "cvd-prevention-2019_sec-7-1_lookup_q01", "question": "What is recommended for individuals with overweight and obesity to improve their ASCVD risk factor profile?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Overweight and Obesity"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 2243}}
{"question_id": "cvd-prevention-2019_sec-7-1_scenario_q01", "question": "A 45-year-old woman with a BMI of 32 presents for a routine check-up. What recommendations should I follow to help her improve her cardiovascular risk profile?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Overweight and Obesity"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 2243}}
{"question_id": "cvd-prevention-2019_sec-7-1_sdm_q01", "question": "How can I effectively communicate the importance of weight loss to a 55-year-old male patient with obesity, considering his concerns about making lifestyle changes?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Overweight and Obesity"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 2243}}
{"question_id": "cvd-prevention-2019_sec-7-3_lookup_q01", "question": "What is the recommended amount of physical activity for adults with obesity to achieve initial weight loss according to the guideline?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 4416}}
{"question_id": "cvd-prevention-2019_sec-7-3_scenario_q01", "question": "For a 60-year-old man with a waist circumference of 42 inches and a BMI of 29, what interventions should I consider to address his increased cardiometabolic risk?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 4416}}
{"question_id": "cvd-prevention-2019_sec-7-3_sdm_q01", "question": "How can I effectively communicate the importance of weight loss to a patient with obesity who is hesitant to start a comprehensive lifestyle intervention, emphasizing the benefits on blood pressure and glucose levels?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 4416}}
{"question_id": "cvd-prevention-2019_sec-7-4_lookup_q01", "question": "What dietary recommendations are made for adults with type 2 diabetes mellitus to improve glycemic control and cardiovascular health?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Type 2 Diabetes Mellitus"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 6009}}
{"question_id": "cvd-prevention-2019_sec-7-4_scenario_q01", "question": "What recommendations should I follow for a 62-year-old woman with type 2 diabetes mellitus whose most recent HbA1c is 7.2%?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Type 2 Diabetes Mellitus"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 6009}}
{"question_id": "cvd-prevention-2019_sec-7-4_sdm_q01", "question": "How can I effectively discuss the importance of lifestyle changes in diet and physical activity with a patient who has type 2 diabetes and is hesitant to change their habits?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With Type 2 Diabetes Mellitus"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 6009}}
{"question_id": "cvd-prevention-2019_sec-7-5_lookup_q01", "question": "What is the significance of type 2 diabetes mellitus (T2DM) as a risk factor for atherosclerotic cardiovascular disease (ASCVD) according to the 2019 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 1125}}
{"question_id": "cvd-prevention-2019_sec-7-5_scenario_q01", "question": "A 45-year-old man who has been diagnosed with prediabetes presents with elevated cholesterol levels. Considering his risk for developing type 2 diabetes, what steps should we take to reduce his ASCVD risk?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 1125}}
{"question_id": "cvd-prevention-2019_sec-7-5_sdm_q01", "question": "My patient is a 55-year-old male with a recent diagnosis of type 2 diabetes and high cholesterol. How can I effectively communicate the importance of lifestyle modifications alongside medication to reduce his cardiovascular risk?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 1125}}
{"question_id": "cvd-prevention-2019_sec-7-7_lookup_q01", "question": "What is the recommended intensity of statin therapy for adults at intermediate risk with a 10-year ASCVD risk of 7.5% to less than 20%?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-7", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-7"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Cholesterol"], "chapter_id": "sec-7", "subtopic_id": "sec-7-7", "char_count": 4800}}
{"question_id": "cvd-prevention-2019_sec-7-7_scenario_q01", "question": "What should we recommend for a 64-year-old woman with an LDL-C level of 200 mg/dL and a 15% 10-year ASCVD risk regarding statin therapy?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-7", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-7"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Cholesterol"], "chapter_id": "sec-7", "subtopic_id": "sec-7-7", "char_count": 4800}}
{"question_id": "cvd-prevention-2019_sec-7-7_sdm_q01", "question": "How can I effectively communicate the benefits of statin therapy to a 65-year-old male patient with an ASCVD risk of 15%, who is hesitant about starting medication due to concerns about side effects?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-7", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-7"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Adults With High Blood Cholesterol"], "chapter_id": "sec-7", "subtopic_id": "sec-7-7", "char_count": 4800}}
{"question_id": "cvd-prevention-2019_sec-7-8_lookup_q01", "question": "What lifestyle recommendations should be emphasized for individuals aged 0-19 years to prevent or reduce ASCVD risk?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-8"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-8", "char_count": 6293}}
{"question_id": "cvd-prevention-2019_sec-7-8_scenario_q01", "question": "For a 55-year-old man with a 10-year ASCVD risk of 12% and an LDL-C of 150 mg/dL, what should be the next steps in his treatment plan?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-8"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-8", "char_count": 6293}}
{"question_id": "cvd-prevention-2019_sec-7-8_sdm_q01", "question": "How can I effectively communicate the importance of lifestyle changes to a 30-year-old patient with a family history of premature ASCVD when discussing their lifetime risk and options for prevention?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-8"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Synopsis"], "chapter_id": "sec-7", "subtopic_id": "sec-7-8", "char_count": 6293}}
{"question_id": "cvd-prevention-2019_sec-7-9_lookup_q01", "question": "What is the recommendation for patients aged 40 to 75 years with diabetes regarding the use of moderate-intensity statin therapy for primary prevention of ASCVD?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-9", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-9"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-9", "char_count": 13930}}
{"question_id": "cvd-prevention-2019_sec-7-9_scenario_q01", "question": "A 62-year-old woman with a history of type 2 diabetes and an LDL-C level of 150 mg/dL presents for a follow-up. Given her age and diabetes status, what is the recommended approach for primary prevention of cardiovascular disease?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-9", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-9"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-9", "char_count": 13930}}
{"question_id": "cvd-prevention-2019_sec-7-9_sdm_q01", "question": "How can I effectively communicate the benefits of high-intensity statin therapy to a 65-year-old male patient with a 10-year ASCVD risk of 20% who is hesitant to start treatment?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-7-9", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-9"], "title_path": ["Other Factors Affecting Cardiovascular Risk", "Recommendation-Specific Supportive Text"], "chapter_id": "sec-7", "subtopic_id": "sec-7-9", "char_count": 13930}}
{"question_id": "cvd-prevention-2019_sec-8_lookup_q01", "question": "What are the key challenges in assessing the value of prevention in apparently healthy patients, according to the 2019 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Cost and Value Considerations"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 3508}}
{"question_id": "cvd-prevention-2019_sec-8_scenario_q01", "question": "How should I approach the treatment plan for a 45-year-old woman who is currently healthy but has a significant family history of heart disease, focusing on cost and value?", "question_style": "scenario", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Cost and Value Considerations"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 3508}}
{"question_id": "cvd-prevention-2019_sec-8_sdm_q01", "question": "How can I explain to my patient the long-term cost-effectiveness of starting statin therapy for primary prevention, considering their concerns about immediate expenses?", "question_style": "sdm", "guideline_id": "cvd-prevention-2019", "guideline_name": "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease", "source": {"node_id": "sec-8", "level": 2, "section_type": "chapter", "path": ["bodymatter", "sec-8"], "title_path": ["Cost and Value Considerations"], "chapter_id": "sec-8", "subtopic_id": "", "char_count": 3508}}
{"question_id": "diabetes-care-2026_ch01-s1_lookup_q01", "question": "What systems should be implemented to support diabetes population health according to the 2026 guidelines?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch01-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch01", "ch01-s1"], "title_path": ["Improving Care and Promoting Health in Populations", "Systems to Support Diabetes Population Health"], "chapter_id": "ch01", "subtopic_id": "ch01-s1", "char_count": 39506}}
{"question_id": "diabetes-care-2026_ch01-s1_scenario_q01", "question": "A 25-year-old man with type 1 diabetes has recently moved to a rural area and is finding it difficult to access healthcare services. What strategies can the care team implement to support his diabetes management and improve his access to care?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch01-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch01", "ch01-s1"], "title_path": ["Improving Care and Promoting Health in Populations", "Systems to Support Diabetes Population Health"], "chapter_id": "ch01", "subtopic_id": "ch01-s1", "char_count": 39506}}
{"question_id": "diabetes-care-2026_ch01-s1_sdm_q01", "question": "How can I effectively communicate the importance of addressing social determinants of health in the diabetes management plan for my patient who is facing economic challenges?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch01-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch01", "ch01-s1"], "title_path": ["Improving Care and Promoting Health in Populations", "Systems to Support Diabetes Population Health"], "chapter_id": "ch01", "subtopic_id": "ch01-s1", "char_count": 39506}}
{"question_id": "diabetes-care-2026_ch02-s2_lookup_q01", "question": "What are the clinical categories for classifying individuals with hyperglycemia according to the 2026 diabetes standards of care?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s2"], "title_path": ["Diagnosis and Classification of Diabetes", "Classification"], "chapter_id": "ch02", "subtopic_id": "ch02-s2", "char_count": 15597}}
{"question_id": "diabetes-care-2026_ch02-s2_scenario_q01", "question": "A 32-year-old woman presents with polyuria and polydipsia. She has a family history of autoimmune diseases and her BMI is 24 kg/m2. What classification should be considered for her hyperglycemia?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s2"], "title_path": ["Diagnosis and Classification of Diabetes", "Classification"], "chapter_id": "ch02", "subtopic_id": "ch02-s2", "char_count": 15597}}
{"question_id": "diabetes-care-2026_ch02-s2_sdm_q01", "question": "How can I effectively communicate the differences between type 1 and type 2 diabetes to a patient who is confused about their diagnosis and management options?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s2"], "title_path": ["Diagnosis and Classification of Diabetes", "Classification"], "chapter_id": "ch02", "subtopic_id": "ch02-s2", "char_count": 15597}}
{"question_id": "diabetes-care-2026_ch02-s6_lookup_q01", "question": "What is the recommended screening timeline for diabetes in individuals who have experienced an episode of acute pancreatitis?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s6"], "title_path": ["Diagnosis and Classification of Diabetes", "Pancreatic Diabetes or Diabetes in the Context of Disease of the Exocrine Pancreas"], "chapter_id": "ch02", "subtopic_id": "ch02-s6", "char_count": 6404}}
{"question_id": "diabetes-care-2026_ch02-s6_scenario_q01", "question": "A 30-year-old male patient with a recent diagnosis of acute pancreatitis and no prior diabetes history presents for follow-up. What should be the next step regarding diabetes screening?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s6"], "title_path": ["Diagnosis and Classification of Diabetes", "Pancreatic Diabetes or Diabetes in the Context of Disease of the Exocrine Pancreas"], "chapter_id": "ch02", "subtopic_id": "ch02-s6", "char_count": 6404}}
{"question_id": "diabetes-care-2026_ch02-s6_sdm_q01", "question": "How can I explain the importance of annual diabetes screening for a patient who recently experienced acute pancreatitis and is concerned about undergoing additional tests?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch02-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch02", "ch02-s6"], "title_path": ["Diagnosis and Classification of Diabetes", "Pancreatic Diabetes or Diabetes in the Context of Disease of the Exocrine Pancreas"], "chapter_id": "ch02", "subtopic_id": "ch02-s6", "char_count": 6404}}
{"question_id": "diabetes-care-2026_ch03-s0A1_lookup_q01", "question": "What is the recommended monitoring frequency for individuals with prediabetes to assess the development of diabetes?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch03", "ch03-s0A1"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Recommendations"], "chapter_id": "ch03", "subtopic_id": "ch03-s0A1", "char_count": 3381}}
{"question_id": "diabetes-care-2026_ch03-s0A1_scenario_q01", "question": "A 3-year-old girl has tested positive for diabetes-related autoantibodies; what is the recommended monitoring approach for her presymptomatic type 1 diabetes?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch03", "ch03-s0A1"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Recommendations"], "chapter_id": "ch03", "subtopic_id": "ch03-s0A1", "char_count": 3381}}
{"question_id": "diabetes-care-2026_ch03-s0A1_sdm_q01", "question": "How can I effectively communicate the importance of regular monitoring for a patient with prediabetes and help them understand the potential long-term benefits of early intervention?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch03", "ch03-s0A1"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Recommendations"], "chapter_id": "ch03", "subtopic_id": "ch03-s0A1", "char_count": 3381}}
{"question_id": "diabetes-care-2026_ch03-s4_lookup_q01", "question": "What care goals should be included for adults with overweight or obesity who are at high risk of developing type 2 diabetes?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch03", "ch03-s4"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Person-Centered Care Goals"], "chapter_id": "ch03", "subtopic_id": "ch03-s4", "char_count": 4589}}
{"question_id": "diabetes-care-2026_ch03-s4_scenario_q01", "question": "A 55-year-old man with a history of gestational diabetes in his wife and a fasting plasma glucose level of 115 mg/dL comes in for advice on preventing diabetes. What should be considered in his care plan?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch03", "ch03-s4"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Person-Centered Care Goals"], "chapter_id": "ch03", "subtopic_id": "ch03-s4", "char_count": 4589}}
{"question_id": "diabetes-care-2026_ch03-s4_sdm_q01", "question": "How can I effectively discuss the importance of weight loss and maintenance with a 55-year-old patient who is at high risk for type 2 diabetes but feels overwhelmed by dietary changes?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch03-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch03", "ch03-s4"], "title_path": ["Prevention or Delay of Diabetes and Associated Comorbidities", "Person-Centered Care Goals"], "chapter_id": "ch03", "subtopic_id": "ch03-s4", "char_count": 4589}}
{"question_id": "diabetes-care-2026_ch04-s4_lookup_q01", "question": "What are the recommended screening practices for adults with type 1 diabetes regarding autoimmune thyroid disease and celiac disease?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch04-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch04", "ch04-s4"], "title_path": ["Comprehensive Medical Evaluation and Assessment of Comorbidities", "Assessment of Comorbidities"], "chapter_id": "ch04", "subtopic_id": "ch04-s4", "char_count": 90940}}
{"question_id": "diabetes-care-2026_ch04-s4_scenario_q01", "question": "A 35-year-old woman with type 1 diabetes has been experiencing gastrointestinal symptoms including abdominal pain and diarrhea. Given her symptoms, should she be screened for celiac disease?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch04-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch04", "ch04-s4"], "title_path": ["Comprehensive Medical Evaluation and Assessment of Comorbidities", "Assessment of Comorbidities"], "chapter_id": "ch04", "subtopic_id": "ch04-s4", "char_count": 90940}}
{"question_id": "diabetes-care-2026_ch04-s4_sdm_q01", "question": "How can I effectively communicate the importance of screening for autoimmune conditions, like thyroid disease and celiac disease, to a newly diagnosed patient with type 1 diabetes who may be hesitant about additional testing?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch04-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch04", "ch04-s4"], "title_path": ["Comprehensive Medical Evaluation and Assessment of Comorbidities", "Assessment of Comorbidities"], "chapter_id": "ch04", "subtopic_id": "ch04-s4", "char_count": 90940}}
{"question_id": "diabetes-care-2026_ch05-s4_lookup_q01", "question": "What is the recommendation for individuals with type 1 diabetes regarding the use of recreational cannabis?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch05-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch05", "ch05-s4"], "title_path": ["Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes", "Smoking Cessation: Tobacco, E-Cigarettes, and Cannabis"], "chapter_id": "ch05", "subtopic_id": "ch05-s4", "char_count": 7882}}
{"question_id": "diabetes-care-2026_ch05-s4_scenario_q01", "question": "A 30-year-old man with type 1 diabetes is using recreational cannabis. What is the best advice I can give him based on current guidelines?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch05-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch05", "ch05-s4"], "title_path": ["Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes", "Smoking Cessation: Tobacco, E-Cigarettes, and Cannabis"], "chapter_id": "ch05", "subtopic_id": "ch05-s4", "char_count": 7882}}
{"question_id": "diabetes-care-2026_ch05-s4_sdm_q01", "question": "How can I communicate the importance of avoiding tobacco and vaping to a patient with diabetes who is hesitant to quit due to stress?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch05-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch05", "ch05-s4"], "title_path": ["Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes", "Smoking Cessation: Tobacco, E-Cigarettes, and Cannabis"], "chapter_id": "ch05", "subtopic_id": "ch05-s4", "char_count": 7882}}
{"question_id": "diabetes-care-2026_ch06-s2_lookup_q01", "question": "What is the recommended A1C goal for many nonpregnant adults without severe hypoglycemia?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch06-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch06", "ch06-s2"], "title_path": ["Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises", "Glycemic Goals"], "chapter_id": "ch06", "subtopic_id": "ch06-s2", "char_count": 23082}}
{"question_id": "diabetes-care-2026_ch06-s2_scenario_q01", "question": "A 62-year-old woman with type 2 diabetes and a recent A1C of 6.8% is concerned about her risk of hypoglycemia. What glycemic target should we set for her to ensure she remains within a safe range?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch06-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch06", "ch06-s2"], "title_path": ["Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises", "Glycemic Goals"], "chapter_id": "ch06", "subtopic_id": "ch06-s2", "char_count": 23082}}
{"question_id": "diabetes-care-2026_ch06-s2_sdm_q01", "question": "How can I effectively communicate the importance of setting individualized glycemic goals to a patient who is concerned about the risks of hypoglycemia associated with their diabetes medications?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch06-s2", "level": 3, "section_type": "container", "path": ["bodymatter", "ch06", "ch06-s2"], "title_path": ["Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises", "Glycemic Goals"], "chapter_id": "ch06", "subtopic_id": "ch06-s2", "char_count": 23082}}
{"question_id": "diabetes-care-2026_ch07-s1_lookup_q01", "question": "What considerations should be taken into account when selecting diabetes devices for individuals whose diabetes management involves caregivers?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch07-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch07", "ch07-s1"], "title_path": ["Diabetes Technology", "General Device Principles"], "chapter_id": "ch07", "subtopic_id": "ch07-s1", "char_count": 10114}}
{"question_id": "diabetes-care-2026_ch07-s1_scenario_q01", "question": "A 7-year-old boy with type 1 diabetes is using a continuous glucose monitor but has not received adequate training on its use. What steps should be taken to ensure both he and his caregivers are properly educated on the device?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch07-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch07", "ch07-s1"], "title_path": ["Diabetes Technology", "General Device Principles"], "chapter_id": "ch07", "subtopic_id": "ch07-s1", "char_count": 10114}}
{"question_id": "diabetes-care-2026_ch07-s1_sdm_q01", "question": "How can I effectively communicate the importance of continuous glucose monitoring (CGM) to a patient who is hesitant about using new technology for their diabetes management?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch07-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch07", "ch07-s1"], "title_path": ["Diabetes Technology", "General Device Principles"], "chapter_id": "ch07", "subtopic_id": "ch07-s1", "char_count": 10114}}
{"question_id": "diabetes-care-2026_ch08-s1_lookup_q01", "question": "What language should health care professionals use when discussing obesity with patients to foster collaboration?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s1"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Assessment and Monitoring of the Individual With Overweight or Obesity"], "chapter_id": "ch08", "subtopic_id": "ch08-s1", "char_count": 9329}}
{"question_id": "diabetes-care-2026_ch08-s1_scenario_q01", "question": "What should I do for a 45-year-old woman with a BMI of 32 who is newly diagnosed with type 2 diabetes and expresses a desire to lose weight?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s1"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Assessment and Monitoring of the Individual With Overweight or Obesity"], "chapter_id": "ch08", "subtopic_id": "ch08-s1", "char_count": 9329}}
{"question_id": "diabetes-care-2026_ch08-s1_sdm_q01", "question": "How can I effectively communicate the importance of weight management to a patient with type 2 diabetes while addressing any potential stigma they might feel?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s1", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s1"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Assessment and Monitoring of the Individual With Overweight or Obesity"], "chapter_id": "ch08", "subtopic_id": "ch08-s1", "char_count": 9329}}
{"question_id": "diabetes-care-2026_ch08-s5_lookup_q01", "question": "What are the criteria for considering metabolic surgery as a management option for individuals with type 2 diabetes and obesity?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s5", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s5"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Metabolic Surgery"], "chapter_id": "ch08", "subtopic_id": "ch08-s5", "char_count": 13080}}
{"question_id": "diabetes-care-2026_ch08-s5_scenario_q01", "question": "A 40-year-old man with type 2 diabetes and a BMI of 35 kg/m2 exhibits signs of anxiety and depression. What additional evaluations should be performed before considering him for metabolic surgery?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s5", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s5"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Metabolic Surgery"], "chapter_id": "ch08", "subtopic_id": "ch08-s5", "char_count": 13080}}
{"question_id": "diabetes-care-2026_ch08-s5_sdm_q01", "question": "How can I effectively communicate the potential benefits and risks of metabolic surgery to a patient with a BMI over 30 who is considering this option for managing their type 2 diabetes?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch08-s5", "level": 3, "section_type": "container", "path": ["bodymatter", "ch08", "ch08-s5"], "title_path": ["Obesity and Weight Management for the Prevention and Treatment of Diabetes", "Metabolic Surgery"], "chapter_id": "ch08", "subtopic_id": "ch08-s5", "char_count": 13080}}
{"question_id": "diabetes-care-2026_ch09-s3_lookup_q01", "question": "What factors should be considered when choosing glucose-lowering medications for adults with type 2 diabetes according to the 2026 standards of care?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch09-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch09", "ch09-s3"], "title_path": ["Pharmacologic Approaches to Glycemic Treatment", "Pharmacologic Therapy for Adults With Type 2 Diabetes"], "chapter_id": "ch09", "subtopic_id": "ch09-s3", "char_count": 56158}}
{"question_id": "diabetes-care-2026_ch09-s3_scenario_q01", "question": "A 65-year-old woman with type 2 diabetes and a history of a myocardial infarction presents with an A1C of 8.5%. What medications should be included in her treatment plan to reduce her cardiovascular risk?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch09-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch09", "ch09-s3"], "title_path": ["Pharmacologic Approaches to Glycemic Treatment", "Pharmacologic Therapy for Adults With Type 2 Diabetes"], "chapter_id": "ch09", "subtopic_id": "ch09-s3", "char_count": 56158}}
{"question_id": "diabetes-care-2026_ch09-s3_sdm_q01", "question": "How can I effectively communicate the potential cardiovascular benefits of GLP-1 RAs to a patient with type 2 diabetes and high cardiovascular risk who is hesitant to start medication?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch09-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch09", "ch09-s3"], "title_path": ["Pharmacologic Approaches to Glycemic Treatment", "Pharmacologic Therapy for Adults With Type 2 Diabetes"], "chapter_id": "ch09", "subtopic_id": "ch09-s3", "char_count": 56158}}
{"question_id": "diabetes-care-2026_ch10-s3_lookup_q01", "question": "What therapeutic strategy should be considered for individuals with hypertension who are not achieving blood pressure goals despite treatment with three classes of antihypertensive medications, including a diuretic?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s3"], "title_path": ["Cardiovascular Disease and Risk Management", "Resistant Hypertension"], "chapter_id": "ch10", "subtopic_id": "ch10-s3", "char_count": 2270}}
{"question_id": "diabetes-care-2026_ch10-s3_scenario_q01", "question": "A 55-year-old man with diabetes has been taking three antihypertensive medications but his blood pressure remains at 135/85 mmHg. What should we consider according to the guideline regarding his treatment options?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s3"], "title_path": ["Cardiovascular Disease and Risk Management", "Resistant Hypertension"], "chapter_id": "ch10", "subtopic_id": "ch10-s3", "char_count": 2270}}
{"question_id": "diabetes-care-2026_ch10-s3_sdm_q01", "question": "How can I effectively communicate the importance of adding MRA therapy to a treatment plan for a patient with resistant hypertension who is already taking multiple antihypertensive medications?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s3", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s3"], "title_path": ["Cardiovascular Disease and Risk Management", "Resistant Hypertension"], "chapter_id": "ch10", "subtopic_id": "ch10-s3", "char_count": 2270}}
{"question_id": "diabetes-care-2026_ch10-s7_lookup_q01", "question": "In asymptomatic individuals with diabetes aged 65 years or older or with microvascular disease, what screening is recommended for peripheral artery disease?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s7", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s7"], "title_path": ["Cardiovascular Disease and Risk Management", "Cardiovascular Disease"], "chapter_id": "ch10", "subtopic_id": "ch10-s7", "char_count": 49096}}
{"question_id": "diabetes-care-2026_ch10-s7_scenario_q01", "question": "A 62-year-old woman with type 2 diabetes and a history of myocardial infarction is being evaluated for her cardiovascular risk. What screening tests should be considered for her?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s7", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s7"], "title_path": ["Cardiovascular Disease and Risk Management", "Cardiovascular Disease"], "chapter_id": "ch10", "subtopic_id": "ch10-s7", "char_count": 49096}}
{"question_id": "diabetes-care-2026_ch10-s7_sdm_q01", "question": "How can I effectively communicate the importance of screening for heart failure in a patient with diabetes who is asymptomatic but has risk factors like age or microvascular disease?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch10-s7", "level": 3, "section_type": "container", "path": ["bodymatter", "ch10", "ch10-s7"], "title_path": ["Cardiovascular Disease and Risk Management", "Cardiovascular Disease"], "chapter_id": "ch10", "subtopic_id": "ch10-s7", "char_count": 49096}}
{"question_id": "diabetes-care-2026_ch11-s4_lookup_q01", "question": "What eGFR levels correspond to stages G1 and G2 of chronic kidney disease as per the 2026 diabetes care guidelines?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch11", "ch11-s4"], "title_path": ["Chronic Kidney Disease and Risk Management", "Staging of Chronic Kidney Disease"], "chapter_id": "ch11", "subtopic_id": "ch11-s4", "char_count": 1270}}
{"question_id": "diabetes-care-2026_ch11-s4_scenario_q01", "question": "A 72-year-old man with a history of hypertension and diabetes has an eGFR of 75 mL/min/1.73 m2 and moderate albuminuria. How should we approach his treatment plan based on his kidney function and albumin levels?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch11", "ch11-s4"], "title_path": ["Chronic Kidney Disease and Risk Management", "Staging of Chronic Kidney Disease"], "chapter_id": "ch11", "subtopic_id": "ch11-s4", "char_count": 1270}}
{"question_id": "diabetes-care-2026_ch11-s4_sdm_q01", "question": "How can I explain to a patient with stage G2 CKD and high albuminuria the importance of monitoring both eGFR and albumin levels in guiding their treatment options?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch11", "ch11-s4"], "title_path": ["Chronic Kidney Disease and Risk Management", "Staging of Chronic Kidney Disease"], "chapter_id": "ch11", "subtopic_id": "ch11-s4", "char_count": 1270}}
{"question_id": "diabetes-care-2026_ch11-s8_lookup_q01", "question": "When should individuals with diabetes be referred to a nephrologist regarding their kidney function?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch11", "ch11-s8"], "title_path": ["Chronic Kidney Disease and Risk Management", "Referral to a Nephrologist"], "chapter_id": "ch11", "subtopic_id": "ch11-s8", "char_count": 2184}}
{"question_id": "diabetes-care-2026_ch11-s8_scenario_q01", "question": "A 50-year-old female patient with type 1 diabetes is presenting with significant increases in albuminuria despite good blood pressure control. Does this warrant a referral to a nephrologist?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch11", "ch11-s8"], "title_path": ["Chronic Kidney Disease and Risk Management", "Referral to a Nephrologist"], "chapter_id": "ch11", "subtopic_id": "ch11-s8", "char_count": 2184}}
{"question_id": "diabetes-care-2026_ch11-s8_sdm_q01", "question": "How can I effectively explain to a patient with diabetes and declining eGFR the importance of a nephrologist referral and the potential benefits of early intervention?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch11-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch11", "ch11-s8"], "title_path": ["Chronic Kidney Disease and Risk Management", "Referral to a Nephrologist"], "chapter_id": "ch11", "subtopic_id": "ch11-s8", "char_count": 2184}}
{"question_id": "diabetes-care-2026_ch13-s0A1_lookup_q01", "question": "What comprehensive assessments should be conducted for older adults with diabetes to determine their management goals and therapeutic approaches?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch13", "ch13-s0A1"], "title_path": ["Older Adults", "Recommendations"], "chapter_id": "ch13", "subtopic_id": "ch13-s0A1", "char_count": 11771}}
{"question_id": "diabetes-care-2026_ch13-s0A1_scenario_q01", "question": "I am caring for a 68-year-old man with diabetes who has a history of falls and is currently taking multiple medications. How should I screen him for geriatric syndromes that may impact his diabetes care?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch13", "ch13-s0A1"], "title_path": ["Older Adults", "Recommendations"], "chapter_id": "ch13", "subtopic_id": "ch13-s0A1", "char_count": 11771}}
{"question_id": "diabetes-care-2026_ch13-s0A1_sdm_q01", "question": "How can I effectively discuss the importance of assessing geriatric syndromes in my older adult patients with diabetes during our shared decision-making conversations?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s0A1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch13", "ch13-s0A1"], "title_path": ["Older Adults", "Recommendations"], "chapter_id": "ch13", "subtopic_id": "ch13-s0A1", "char_count": 11771}}
{"question_id": "diabetes-care-2026_ch13-s4_lookup_q01", "question": "What is the recommended protein intake for older adults with diabetes to maintain or regain lean body mass?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s4"], "title_path": ["Older Adults", "Lifestyle Management"], "chapter_id": "ch13", "subtopic_id": "ch13-s4", "char_count": 4730}}
{"question_id": "diabetes-care-2026_ch13-s4_scenario_q01", "question": "How can I tailor a physical activity program for a 75-year-old woman with type 2 diabetes who has been diagnosed with frailty and is at risk of mobility disability?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s4"], "title_path": ["Older Adults", "Lifestyle Management"], "chapter_id": "ch13", "subtopic_id": "ch13-s4", "char_count": 4730}}
{"question_id": "diabetes-care-2026_ch13-s4_sdm_q01", "question": "How can I effectively communicate the importance of adequate protein intake to a frail older adult with diabetes who is concerned about dietary changes?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s4", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s4"], "title_path": ["Older Adults", "Lifestyle Management"], "chapter_id": "ch13", "subtopic_id": "ch13-s4", "char_count": 4730}}
{"question_id": "diabetes-care-2026_ch13-s8_lookup_q01", "question": "What are the primary goals for diabetes management in older adults receiving palliative care?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s8"], "title_path": ["Older Adults", "End-of-Life Care"], "chapter_id": "ch13", "subtopic_id": "ch13-s8", "char_count": 5832}}
{"question_id": "diabetes-care-2026_ch13-s8_scenario_q01", "question": "A 82-year-old man with type 1 diabetes is nearing the end of life and has significantly reduced oral intake. Should he continue his insulin regimen, and if so, what adjustments should be made?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s8"], "title_path": ["Older Adults", "End-of-Life Care"], "chapter_id": "ch13", "subtopic_id": "ch13-s8", "char_count": 5832}}
{"question_id": "diabetes-care-2026_ch13-s8_sdm_q01", "question": "How can I initiate a conversation with a patient and their family about the goals of diabetes management in the context of palliative care, ensuring they understand the shift from strict control to prioritizing comfort and quality of life?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch13-s8", "level": 3, "section_type": "container", "path": ["bodymatter", "ch13", "ch13-s8"], "title_path": ["Older Adults", "End-of-Life Care"], "chapter_id": "ch13", "subtopic_id": "ch13-s8", "char_count": 5832}}
{"question_id": "diabetes-care-2026_ch14-s4_lookup_q01", "question": "What A1C goal is recommended for most children and adolescents with type 1 diabetes, and what is the consideration for those who can achieve lower levels without adverse effects?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch14-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch14", "ch14-s4"], "title_path": ["Children and Adolescents", "Type 1 Diabetes in Children and Adolescents"], "chapter_id": "ch14", "subtopic_id": "ch14-s4", "char_count": 7996}}
{"question_id": "diabetes-care-2026_ch14-s4_scenario_q01", "question": "A 10-year-old girl with type 1 diabetes was recently diagnosed and is currently in the honeymoon phase. What A1C goal should be recommended for her?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch14-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch14", "ch14-s4"], "title_path": ["Children and Adolescents", "Type 1 Diabetes in Children and Adolescents"], "chapter_id": "ch14", "subtopic_id": "ch14-s4", "char_count": 7996}}
{"question_id": "diabetes-care-2026_ch14-s4_sdm_q01", "question": "How can I effectively communicate the importance of achieving lower A1C goals to a parent of a child with type 1 diabetes, especially considering potential risks and benefits?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch14-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch14", "ch14-s4"], "title_path": ["Children and Adolescents", "Type 1 Diabetes in Children and Adolescents"], "chapter_id": "ch14", "subtopic_id": "ch14-s4", "char_count": 7996}}
{"question_id": "diabetes-care-2026_ch15-s1_lookup_q01", "question": "What A1C level should individuals with diabetes and childbearing potential aim to achieve prior to conception to reduce the risk of congenital anomalies and other complications?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch15", "ch15-s1"], "title_path": ["Management of Diabetes in Pregnancy", "Diabetes in Pregnancy"], "chapter_id": "ch15", "subtopic_id": "ch15-s1", "char_count": 18113}}
{"question_id": "diabetes-care-2026_ch15-s1_scenario_q01", "question": "A 28-year-old woman with type 1 diabetes is planning her first pregnancy. What should her A1C target be before conception to minimize risks to her and her baby?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch15", "ch15-s1"], "title_path": ["Management of Diabetes in Pregnancy", "Diabetes in Pregnancy"], "chapter_id": "ch15", "subtopic_id": "ch15-s1", "char_count": 18113}}
{"question_id": "diabetes-care-2026_ch15-s1_sdm_q01", "question": "How can I effectively communicate the importance of preconception counseling to a young woman with diabetes who is planning to become pregnant, especially regarding achieving optimal A1C levels to minimize risks for congenital anomalies?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch15", "ch15-s1"], "title_path": ["Management of Diabetes in Pregnancy", "Diabetes in Pregnancy"], "chapter_id": "ch15", "subtopic_id": "ch15-s1", "char_count": 18113}}
{"question_id": "diabetes-care-2026_ch15-s6_lookup_q01", "question": "What insulin adjustments should be made for individuals requiring insulin immediately after delivery due to the dramatic decrease in insulin resistance postpartum?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch15", "ch15-s6"], "title_path": ["Management of Diabetes in Pregnancy", "Postpartum Care"], "chapter_id": "ch15", "subtopic_id": "ch15-s6", "char_count": 9380}}
{"question_id": "diabetes-care-2026_ch15-s6_scenario_q01", "question": "For a 28-year-old female patient with a history of gestational diabetes who is breastfeeding, how can we support her to minimize the risk of hypoglycemia during this period?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch15", "ch15-s6"], "title_path": ["Management of Diabetes in Pregnancy", "Postpartum Care"], "chapter_id": "ch15", "subtopic_id": "ch15-s6", "char_count": 9380}}
{"question_id": "diabetes-care-2026_ch15-s6_sdm_q01", "question": "How can I effectively communicate the importance of establishing a contraceptive plan for my patient with diabetes after delivery, considering her potential concerns about medication and family planning options?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch15-s6", "level": 3, "section_type": "container", "path": ["bodymatter", "ch15", "ch15-s6"], "title_path": ["Management of Diabetes in Pregnancy", "Postpartum Care"], "chapter_id": "ch15", "subtopic_id": "ch15-s6", "char_count": 9380}}
{"question_id": "diabetes-care-2026_ch16-s12_lookup_q01", "question": "What tools or technologies are mentioned as facilitating diabetes management in hospitals according to the 2026 standards of care?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s12", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s12"], "title_path": ["Diabetes Care in the Hospital", "The Future"], "chapter_id": "ch16", "subtopic_id": "ch16-s12", "char_count": 1133}}
{"question_id": "diabetes-care-2026_ch16-s12_scenario_q01", "question": "What is the recommended approach for a 70-year-old man with type 1 diabetes who has been admitted for a stroke and is at risk for both hypoglycemia and hyperglycemia?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s12", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s12"], "title_path": ["Diabetes Care in the Hospital", "The Future"], "chapter_id": "ch16", "subtopic_id": "ch16-s12", "char_count": 1133}}
{"question_id": "diabetes-care-2026_ch16-s12_sdm_q01", "question": "How can I effectively communicate the importance of using decision support tools in managing my patient's diabetes during their hospital stay?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s12", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s12"], "title_path": ["Diabetes Care in the Hospital", "The Future"], "chapter_id": "ch16", "subtopic_id": "ch16-s12", "char_count": 1133}}
{"question_id": "diabetes-care-2026_ch16-s4_lookup_q01", "question": "What is the recommended frequency of point-of-care blood glucose monitoring for hospitalized patients with diabetes who are not eating?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s4"], "title_path": ["Diabetes Care in the Hospital", "Glucose Monitoring"], "chapter_id": "ch16", "subtopic_id": "ch16-s4", "char_count": 7987}}
{"question_id": "diabetes-care-2026_ch16-s4_scenario_q01", "question": "A 45-year-old man with type 2 diabetes is hospitalized and currently using an insulin pump. What recommendations should be followed to ensure safe use of the pump during his stay?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s4"], "title_path": ["Diabetes Care in the Hospital", "Glucose Monitoring"], "chapter_id": "ch16", "subtopic_id": "ch16-s4", "char_count": 7987}}
{"question_id": "diabetes-care-2026_ch16-s4_sdm_q01", "question": "How can I effectively discuss the benefits and limitations of using point-of-care blood glucose monitoring versus continuous glucose monitoring with a patient who is uncertain about which method to choose during their hospitalization?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s4"], "title_path": ["Diabetes Care in the Hospital", "Glucose Monitoring"], "chapter_id": "ch16", "subtopic_id": "ch16-s4", "char_count": 7987}}
{"question_id": "diabetes-care-2026_ch16-s8_lookup_q01", "question": "What criteria must be met for patients with diabetes to continue self-management during hospitalization?", "question_style": "lookup", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s8"], "title_path": ["Diabetes Care in the Hospital", "Self-Management in the Hospital"], "chapter_id": "ch16", "subtopic_id": "ch16-s8", "char_count": 1603}}
{"question_id": "diabetes-care-2026_ch16-s8_scenario_q01", "question": "A 75-year-old man with a history of diabetes and recent cognitive decline is admitted after a fall. His family is present and willing to assist. Is he a suitable candidate for managing his diabetes care independently while hospitalized?", "question_style": "scenario", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s8"], "title_path": ["Diabetes Care in the Hospital", "Self-Management in the Hospital"], "chapter_id": "ch16", "subtopic_id": "ch16-s8", "char_count": 1603}}
{"question_id": "diabetes-care-2026_ch16-s8_sdm_q01", "question": "How can I effectively communicate to a patient with diabetes the importance of agreeing with the care team on daily self-management decisions during their hospital stay?", "question_style": "sdm", "guideline_id": "diabetes-care-2026", "guideline_name": "Standards of Care in Diabetes—2026", "source": {"node_id": "ch16-s8", "level": 3, "section_type": "subsection", "path": ["bodymatter", "ch16", "ch16-s8"], "title_path": ["Diabetes Care in the Hospital", "Self-Management in the Hospital"], "chapter_id": "ch16", "subtopic_id": "ch16-s8", "char_count": 1603}}
{"question_id": "dyslipidemia-2026_sec-6-1_lookup_q01", "question": "What are the key characteristics of cardiovascular-kidney-metabolic syndrome as defined in the 2026 ACC/AHA guideline?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classifications", "Definitions"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2190}}
{"question_id": "dyslipidemia-2026_sec-6-1_scenario_q01", "question": "What management strategies should I consider for a 45-year-old woman with a BMI of 32, type 2 diabetes, and low HDL-C levels?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classifications", "Definitions"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2190}}
{"question_id": "dyslipidemia-2026_sec-6-1_sdm_q01", "question": "How can I effectively communicate the importance of lifestyle management to a patient with CKM syndrome who is hesitant to make changes to their diet and exercise routine?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-6-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-6", "sec-6-1"], "title_path": ["Definitions and Classifications", "Definitions"], "chapter_id": "sec-6", "subtopic_id": "sec-6-1", "char_count": 2190}}
{"question_id": "dyslipidemia-2026_sec-7-1_lookup_q01", "question": "What is the recommended age to start screening adults with a lipid profile to identify ASCVD risk according to the 2026 ACC/AHA guidelines?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Screening in Children and Adults"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 8370}}
{"question_id": "dyslipidemia-2026_sec-7-1_scenario_q01", "question": "Should I screen a 10-year-old boy who has no prior lipid testing but has a family history of premature heart disease?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Screening in Children and Adults"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 8370}}
{"question_id": "dyslipidemia-2026_sec-7-1_sdm_q01", "question": "How can I effectively communicate the importance of lipid profile screening to a 10-year-old patient's parents, especially considering the risks of familial hypercholesterolemia and the need for early identification?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-1"], "title_path": ["Evaluation and Diagnosis", "Screening in Children and Adults"], "chapter_id": "sec-7", "subtopic_id": "sec-7-1", "char_count": 8370}}
{"question_id": "dyslipidemia-2026_sec-7-2_lookup_q01", "question": "What lipid profile is recommended to estimate ASCVD risk and guide initiation of lipid-lowering therapy in adults and children?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 9646}}
{"question_id": "dyslipidemia-2026_sec-7-2_scenario_q01", "question": "A 62-year-old woman with a family history of premature cardiovascular disease presents for her annual check-up. Her recent nonfasting lipid profile shows a triglyceride level of 450 mg/dL. What type of lipid profile does the guideline recommend for her?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 9646}}
{"question_id": "dyslipidemia-2026_sec-7-2_sdm_q01", "question": "How should I explain to a patient with a family history of premature ASCVD the importance of a fasting lipid profile to accurately estimate their LDL-C levels?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-2"], "title_path": ["Evaluation and Diagnosis", "Measurement of TC, LDL-C, HDL-C, TG, and Non–HDL-C"], "chapter_id": "sec-7", "subtopic_id": "sec-7-2", "char_count": 9646}}
{"question_id": "dyslipidemia-2026_sec-7-3_lookup_q01", "question": "What is the recommendation for measuring apoB in adults on lipid-lowering therapy with a history of ASCVD, CKM syndrome, type 2 diabetes, and/or elevated triglycerides once LDL-C and/or non-HDL-C goals are reached?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Evaluation and Diagnosis", "Measurement of ApoB"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 6820}}
{"question_id": "dyslipidemia-2026_sec-7-3_scenario_q01", "question": "A 50-year-old man without any history of cardiovascular disease or lipid-lowering therapy presents with a family history of hyperlipidemia. Is it advisable to measure his apoB levels to assess his risk for atherosclerotic cardiovascular disease?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Evaluation and Diagnosis", "Measurement of ApoB"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 6820}}
{"question_id": "dyslipidemia-2026_sec-7-3_sdm_q01", "question": "How can I explain the importance of measuring apoB to my patient with diabetes and high LDL, especially in terms of guiding their treatment options after reaching LDL-C goals?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-3", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-3"], "title_path": ["Evaluation and Diagnosis", "Measurement of ApoB"], "chapter_id": "sec-7", "subtopic_id": "sec-7-3", "char_count": 6820}}
{"question_id": "dyslipidemia-2026_sec-7-4_lookup_q01", "question": "What is the recommendation for measuring Lp(a) concentration in all adults for ASCVD risk assessment?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Evaluation and Diagnosis", "Measurement of Lp(a)"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 7602}}
{"question_id": "dyslipidemia-2026_sec-7-4_scenario_q01", "question": "A 62-year-old woman with a family history of premature atherosclerotic cardiovascular disease (ASCVD) presents for a routine check-up. Should we measure her lipoprotein(a) levels to assess her ASCVD risk?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Evaluation and Diagnosis", "Measurement of Lp(a)"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 7602}}
{"question_id": "dyslipidemia-2026_sec-7-4_sdm_q01", "question": "How can I explain the importance of measuring Lp(a) levels to a patient with a family history of premature ASCVD, and what should I say to address any concerns they may have about the testing process?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-4", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-4"], "title_path": ["Evaluation and Diagnosis", "Measurement of Lp(a)"], "chapter_id": "sec-7", "subtopic_id": "sec-7-4", "char_count": 7602}}
{"question_id": "dyslipidemia-2026_sec-7-5_lookup_q01", "question": "What is the recommended frequency for performing a lipid profile in individuals on lipid-lowering therapy after initiation or dose adjustment?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Evaluation and Diagnosis", "Monitoring and Follow-Up"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 7842}}
{"question_id": "dyslipidemia-2026_sec-7-5_scenario_q01", "question": "A 55-year-old man with severe hypercholesterolemia has just initiated lipid-lowering therapy. How soon after starting his medication should he have his first lipid profile done?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Evaluation and Diagnosis", "Monitoring and Follow-Up"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 7842}}
{"question_id": "dyslipidemia-2026_sec-7-5_sdm_q01", "question": "How can I effectively communicate to my patient the importance of regular lipid profile testing after starting lipid-lowering therapy, especially considering their previous adherence challenges?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-7-5", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-7", "sec-7-5"], "title_path": ["Evaluation and Diagnosis", "Monitoring and Follow-Up"], "chapter_id": "sec-7", "subtopic_id": "sec-7-5", "char_count": 7842}}
{"question_id": "dyslipidemia-2026_sec-8-1_lookup_q01", "question": "What dietary patterns should be promoted in children and healthy adults to reduce the risk of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-8", "sec-8-1"], "title_path": ["Management", "Lifestyle Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-1", "char_count": 40549}}
{"question_id": "dyslipidemia-2026_sec-8-1_scenario_q01", "question": "A 38-year-old woman recently diagnosed with dyslipidemia is concerned about her lipid levels. She is currently sedentary and has not engaged in regular exercise. What guidelines should be recommended for her physical activity to improve her cardiovascular health?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-8", "sec-8-1"], "title_path": ["Management", "Lifestyle Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-1", "char_count": 40549}}
{"question_id": "dyslipidemia-2026_sec-8-1_sdm_q01", "question": "How can I effectively communicate the importance of a heart-healthy diet and lifestyle changes to a 45-year-old male patient with high LDL cholesterol who is skeptical about dietary modifications?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-8", "sec-8-1"], "title_path": ["Management", "Lifestyle Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-1", "char_count": 40549}}
{"question_id": "dyslipidemia-2026_sec-8-2_lookup_q01", "question": "What is the recommended initial pharmacotherapy for adults with severe hypercholesterolemia (LDL-C ≥190 mg/dL) who do not have clinical ASCVD?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-8", "sec-8-2"], "title_path": ["Management", "Medical Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-2", "char_count": 390822}}
{"question_id": "dyslipidemia-2026_sec-8-2_scenario_q01", "question": "A 35-year-old man presents with severe hypertriglyceridemia, with levels exceeding 1000 mg/dL, and a recent hospitalization for pancreatitis. What immediate actions should be taken to manage his triglyceride levels?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-8", "sec-8-2"], "title_path": ["Management", "Medical Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-2", "char_count": 390822}}
{"question_id": "dyslipidemia-2026_sec-8-2_sdm_q01", "question": "How can I effectively discuss the potential benefits and risks of initiating statin therapy with a 70-year-old male patient who has a history of heart disease and is concerned about possible side effects?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-8-2", "level": 3, "section_type": "container", "path": ["bodymatter", "sec-8", "sec-8-2"], "title_path": ["Management", "Medical Management"], "chapter_id": "sec-8", "subtopic_id": "sec-8-2", "char_count": 390822}}
{"question_id": "dyslipidemia-2026_sec-9-1_lookup_q01", "question": "What is recommended for adults with dyslipidemia before starting lipid-lowering medication to enhance patient adherence?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["Complications of Management", "Medication Safety and Therapy-Associated Side Effects"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 17197}}
{"question_id": "dyslipidemia-2026_sec-9-1_scenario_q01", "question": "A 62-year-old woman with a history of dyslipidemia and stable chronic liver disease is considering starting statin therapy. What does the guideline recommend for her regarding the initiation of lipid-lowering medication?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["Complications of Management", "Medication Safety and Therapy-Associated Side Effects"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 17197}}
{"question_id": "dyslipidemia-2026_sec-9-1_sdm_q01", "question": "How can I effectively communicate the importance of discussing the risks and benefits of statin therapy with a patient who has dyslipidemia before starting treatment?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-1", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-1"], "title_path": ["Complications of Management", "Medication Safety and Therapy-Associated Side Effects"], "chapter_id": "sec-9", "subtopic_id": "sec-9-1", "char_count": 17197}}
{"question_id": "dyslipidemia-2026_sec-9-2_lookup_q01", "question": "What is recommended for adults starting statin therapy regarding their other cardiovascular medications to reduce the risk of adverse events?", "question_style": "lookup", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["Complications of Management", "Statin-Cardiovascular Drug Interactions"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 6790}}
{"question_id": "dyslipidemia-2026_sec-9-2_scenario_q01", "question": "A 55-year-old man with hyperlipidemia is already on simvastatin and is now prescribed diltiazem for hypertension. What is the recommended action for managing his statin therapy?", "question_style": "scenario", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["Complications of Management", "Statin-Cardiovascular Drug Interactions"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 6790}}
{"question_id": "dyslipidemia-2026_sec-9-2_sdm_q01", "question": "When discussing the initiation of statin therapy with a patient who is currently taking multiple cardiovascular medications, how should I explain the importance of reviewing for potential drug interactions to minimize adverse events?", "question_style": "sdm", "guideline_id": "dyslipidemia-2026", "guideline_name": "2026 ACC/AHA Guideline on the Management of Dyslipidemia", "source": {"node_id": "sec-9-2", "level": 3, "section_type": "subsection", "path": ["bodymatter", "sec-9", "sec-9-2"], "title_path": ["Complications of Management", "Statin-Cardiovascular Drug Interactions"], "chapter_id": "sec-9", "subtopic_id": "sec-9-2", "char_count": 6790}}